Future treatment

Bailliere's Clinical Rheumatology

Volumn 11, Issue 1, 1997, Pages 83-96

  Breedveld, F C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biological agents; Monoclonal antibodies; Rheumatoid arthritis; Vaccination

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CDW52 ANTIGEN; HLA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE; ANTIRHEUMATIC AGENT;

AUTOIMMUNITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; HUMAN; RHEUMATOLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; RHEUMATOLOGY;

EID: 0031063472     PISSN: 09503579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3579(97)80034-9     Document Type: Article

References (42)

1. Adorini L Nagy ZA Peptide competition for antigen presentation Immunology Today 11 1990 21 24
2. Ben-Nun A Wekerle H Cohen IR Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein Nature 292 1981 60 62
3. Campion GV Lebsack ME Lookabough J Dose range and dose frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis Arthritis and Rheumatism 39 1996 1092 1101
4. Choy EHS Chikanza IC Kingsley GH Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti CD4 monoclonal antibodies Scandinavian Journal of Rheumatology 36 1992 291 298
5. Cohen SBA Katsikes PB Chu CQ High levels of interleukin 10 production by activated T cell population within the synovial membrane Arthritis and Rheumatism 38 1995 946 952
6. Combe B Cosso B Bonneau M Sany J Human placenta-eluted gammaglobins in immunomodulating treatment of rheumatoid arthritis American Journal of Medicine 78 1985 920 928
7. Drevlow BE Lovis R Haag MA Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis Arthritis and Rheumatism 39 1996 257 266
8. Elliot MJ Maine RN Feldmann M Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha Arthritis and Rheumatism 36 1993 1681 1690
9. Elliot MJ Maini RM Feldmann M Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1104 1110
10. Elliot MJ Maini RN Feldmann M Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2)in patients with rheumatoid arthritis Lancet 344 1994 1125 1127
11. Feldmann M Brennan FM Maini RN Rheumatoid arthritis Cell 85 1996 307 310
12. Hofschneider PH Winter U Lemmel EM Double-blind controlled phase III multicentre clinical trial with interferon gamma in rheumatoid arthritis Rheumatology International 12 1992 175 182
13. Isaacs JD Manna VK Hazleman BL Campath-1H in rheumatoid arthritis. A study on multiple IV-dosing Arthritis and Rheumatism 36 1993 S40
14. Janeway CA Haque S Smith LA Saizawa K The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies Journal of Molecular and Cellular Immunology 3 1987 121 131
15. Kavanaugh AF Davis LS Nichols LE Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intracellular adhesion molecule Arthritis and Rheumatism 37 1994 992 999
16. Kingsley G Verwilghen J Chikanza I Panayi GS T cell vaccination (TCV) in rheumatoid arthritis (RA): a controlled double-blind pilot study Arthritis and Rheumatism 35 1992 S44
17. Kirkham BW Thien F Pelton BK Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis Journal of Rheumatology 19 1992 1348 1352
18. Kyle V Coughlan RJ Tighe H Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis Annals of the Rheumatic Diseases 48 1989 428 429
19. van Laar JM Miltenburg AMM Verdonk MJA Effects of inoculation with attenuated autologous T-cells in patients with rheumatoid arthritis Journal of Autoimmunity 6 1993 159 167
20. Lohse AW Bakker NPM Hermann E Induction of an anti-vaccine response by T cell vaccination in non-human primates and humans Journal of Autoimmunity 1 1993 121 124
21. van der Lubbe PA Dijkmans BAC Markusse HM A randomized double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis Arthritis and Rheumatism 38 1995 1097 1106
22. Mor F Cohen IR Vaccines to prevent and treat autoimmune diseases Internal Archives of Allergy and Applied Immunology 108 1995 345 349
23. Moreland LW Heck IW Koopman WJ Vβ17 T cell receptor peptide vaccine: results of a phase I dose-finding study in patients with rheumatoid arthritis Arthritis and Rheumatism 37 1994 S337
24. Moreland LW Margolies GR Heck IW Soluble tumor necrosis factor receptor. Results of phase I dose-escalation study in patients with rheumatoid arthritis Arthritis and Rheumatism 37 1994 S295
25. Moreland LW Pratt PW Mayes MD Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate Arthritis and Rheumatism 38 1995 1568 1580
26. Moreland LW Sewell KL Trentham DE Interleukin-2 diphtheria fusion protein (DAB486-IL-2) in refractory rheumatoid arthritis Arthritis and Rheumatism 38 1995 1177 1186
27. Olsen NJ Brooks RH Cush JJ A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis Arthritis and Rheumatism 39 1996 1102 1108
28. Panayi GS Lanchbury JS Kingsley GH The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis Arthritis and Rheumatism 35 1992 729 735
29. Parish NM Hutchings PR Waldman Tolerance to IDDM induced by CD4 antibodies in nonobese diabetic mice is reversed by cyclophosphamide Diabetes 42 1993 1601 1605
30. Pratt W Heck L Moreland L Safety and immunogenicity of a single intramuscular injection of a synthetic HLA-DR4/1 peptide vaccine with alum adjuvant in rheumatoid arthritis patients Arthritis and Rheumatism 38 1995 S281
31. Quagliata F Schenkelaars EJ Ferrone S Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4 Israel Journal of Medical Sciences 29 1993 154 159
32. ( supplement ) Rankin ECC Choy EHS Kassimos D A double-blind, placebo-controlled, ascending dose trial of the recombinant humanised anti TNFα antibody CDP571 in patients with rheumatoid arthritis Arthritis and Rheumatism 37 1994 S295
33. Sewell KL Moreland LW Cush JJ Phase I/II double-blind dose response trial of a second fusion toxin DAB389-IL-2 in rheumatoid arthritis Arthritis and Rheumatism 36 1993 S130
34. Sieper J Kary S Sörensen H Oral type II collagen treatment in early rheumatoid arthritis: a double blind, placebo-controlled randomized trial Arthritis and Rheumatism 39 1996 41 52
35. Tak PP Lubbe van der PA Cauli A Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis Arthritis and Rheumatism 38 1995 1457 1465
36. Trentham DE Dynesius-Trentham RA Orav EJ Effects of oral administration of type II collagen on rheumatoid arthritis Science 261 1993 1669 1670
37. Waal Malefijt de R Yssel H de Vries JE Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells Journal of Immunology 150 1993 4754 4765
38. Weinblatt ME Maddison PJ Bulpitt KJ Campath-1H, a humanized monoclonal antibody in refractory rheumatoid arthritis Arthritis and Rheumatism 38 1995 1589 1594
39. Weiner HL Friedman A Miller A Oral tolerance: immunologic mechanisms and treatment of animal and human organ specific autoimmune diseases by oral administration of autoantigens Annual Review of Immunology 12 1994 809 837
40. Williams RO Mason LJ Feldman M Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis Proceedings of the National Academy of Sciences of the USA 91 1994 2762 2766
41. ( supplement ) Yocum DE Nordensson K Solinger AM Immunomodulatory effect of primatized IDEC-CE9.1, an anti-CD4 monoclonal antibody in rheumatoid arthritis Arthritis and Rheumatism 37 1994 S336
42. Zhang J Medaer R Stinissen P MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination Science 261 1993 1451 1454